Neoadjuvant and perioperative immunotherapy in resectable non-small cell lung cancer (NSCLC): A systematic review and extracted individual patient data meta-analysis

被引:0
|
作者
Cunha, Mateus Trinconi Trinconi
Sperandio, Rubens Copia
Chan, Kelvin K.
Menjak, Ines B.
机构
[1] Univ Toronto, Odette Canc Ctr, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8045
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis
    Wu, Yajing
    Verma, Vivek
    Gay, Carl M.
    Chen, Yujia
    Liang, Fei
    Lin, Qiang
    Wang, Jianing
    Zhang, Wei
    Hui, Zhouguang
    Zhao, Min
    Wang, Jun
    Chang, Joe Y.
    [J]. CANCER, 2023, 129 (13) : 1969 - 1985
  • [2] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis
    Syaj, S.
    Akhdar, M.
    Ababneh, O.
    Hamouri, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S235 - S236
  • [3] Meta-Analysis of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer
    Cao, Christopher
    Le, Anthony
    Bott, Matthew
    Yang, Chi-Fu Jeffrey
    Gossot, Dominique
    Melfi, Franca
    Tian, David H.
    Guo, Allen
    [J]. CURRENT ONCOLOGY, 2021, 28 (06) : 4686 - 4701
  • [4] Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis
    Wang, He
    Liu, Tingting
    Chen, Jun
    Dang, Jun
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
    Jiang, Juan
    Wang, Yuling
    Gao, Yang
    Sugimura, Haruhiko
    Minervini, Fabrizio
    Uchino, Junji
    Halmos, Balazs
    Yendamuri, Sai
    Velotta, Jeffrey B.
    Li, Min
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (02) : 277 - +
  • [6] Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis
    Han, Yuelin
    Xiao, Xiangtian
    Qin, Tingting
    Yao, Shuxi
    Liu, Xinyue
    Feng, Yanqi
    Li, Zhou
    Li, Yiming
    Xia, Shu
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [7] Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis
    Ye, Linlin
    Liu, Yao
    Xiang, Xuan
    Wang, Zihao
    Wei, Xiaoshan
    Peng, Wenbei
    Zhang, Siyu
    Xue, Qianqian
    Zhou, Qiong
    [J]. HELIYON, 2024, 10 (11)
  • [8] Chemotherapy in non-small cell lung cancer (NSCLC): An individual patient data meta-analysis
    Burdett, S
    Auperin, A
    Stewart, L
    Pignon, J
    [J]. LUNG CANCER, 2005, 49 : S168 - S168
  • [9] Efficacy and safety of neoadjuvant immunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
    Xu, Ke
    Ni, Juan
    Wu, Xiaodi
    Xie, Jingyuan
    Chen, Mo
    Zhang, Fang
    Liu, Hongbing
    Zhan, Ping
    Lv, Tangfeng
    Song, Yong
    [J]. AME MEDICAL JOURNAL, 2022, 7
  • [10] Pathological response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer (NSCLC): A systematic review and meta-analysis.
    Syaj, Sebawe
    Akhdar, Marah
    Ababneh, Obada Ehab
    Hamouri, Shadi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)